Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults
Natalie McCarthy(Centers for Disease Control and Prevention), Michael M. McNeil(Centers for Disease Control and Prevention), Jonathan Duffy(Centers for Disease Control and Prevention), Elyse O. Kharbanda(HealthPartners), Stephanie A. Irving(Kaiser Permanente Center for Health Research), Eric Weintraub, Jennifer P. King(Marshfield Clinic), Julianne Gee, Lakshmi Sukumaran, Matthew F. Daley(Kaiser Permanente), Roger Baxter(Unknown), Rulin C. Hechter(Kaiser Permanente)
Cited by 12
Related Papers
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
|JAMA Network Open|2020|614
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602